Sigurjonsdottir G, De Marchi T, Ehinger A, Hartman J, et al. Comparison of SP142 and 22C3 PD-L1 assays in a population-based cohort of triple-negative breast cancer patients in the context of their clinically established scoring algorithms. Breast Cancer Res 2023;25:123.
PMID: 37817263